| Name | Title | Contact Details |
|---|
Ethos is a life insurance company founded in 2016 by Peter Colis and Lingke Wang. The company focuses on making life insurance more affordable and accessible by using technology to simplify the application process. Ethos operates as a licensed insurance agency, partnering with third-party carriers like Legal & General America, TruStage, and Ameritas. Ethos offers an online application process that provides instant quotes, allowing customers to apply for life insurance quickly. The company utilizes a proprietary underwriting engine to assess health and eligibility, ensuring suitable coverage options. Ethos also supports a network of independent insurance agents, facilitating both direct-to-consumer and agent-assisted sales. The primary product offered is term life insurance, tailored to meet individual needs. With significant funding from investors such as Sequoia, Accel, Google Ventures, Goldman Sachs, and Softbank, Ethos has established itself as a major player in the U.S. life insurance market, aiming to protect millions of families.
STARK Group is a leading provider of building materials and services for the construction industry in Europe. Founded in 1896 and headquartered in Frederiksberg, Denmark, the company operates over 1,100 branches and distribution centers across Europe, employing around 19,000 people. STARK Group specializes in the distribution and retail of building materials to professional builders and contractors. They offer product knowledge and advice to help customers select the right materials for their projects. The company also provides efficient logistics solutions to ensure timely delivery of products to construction sites. Their extensive product portfolio includes a wide range of heavy construction materials tailored to meet the diverse needs of the construction sector. STARK Group is committed to sustainability, investing in environmentally friendly facilities and aiming for low-emission classifications in their operations.
Synonym is accelerating the worlds biological future by developing, financing and building commercial-scale biomanufacturing facilities. We provide synthetic biology (synbio) producers – from startups to the Fortune 500 – with flexible production capacity while giving infrastructure investors access to a new, carbon-negative biomanufacturing asset class that we are calling "fermentation farms".